Holen Sie sich die Stockscreener-App
111.49
0.06%
-0.1362
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt A?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Agilent Technologies Inc Aktie (A) Neueste Nachrichten
Magnetar Financial LLC Decreases Holdings in Agilent Technologies, Inc. $A - MarketBeat
Schroder Investment Management Group Buys 75,796 Shares of Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies, Inc. $A Shares Purchased by Natixis Advisors LLC - MarketBeat
Preventive Control Of Sequencing Through The Insert With The Agilent 5200 Fragment Analyzer System - bioprocessonline.com
Agilent Expands CDMO Role With Advanced Therapeutics As Shares Lag Targets - simplywall.st
Agilent Technologies, Inc. (A) price target cut to $155 at Baird - MSN
Vestcor Inc Sells 10,204 Shares of Agilent Technologies, Inc. $A - MarketBeat
Mackenzie Financial Corp Buys 324,461 Shares of Agilent Technologies, Inc. $A - MarketBeat
Agilent unifies CDMO capabilities across Canada and United States - BioSpectrum India
Legal & General Group Plc Raises Position in Agilent Technologies, Inc. $A - MarketBeat
Korea Investment CORP Has $12.95 Million Stake in Agilent Technologies, Inc. $A - MarketBeat
Agilent launches unified CDMO business combining US, Canada units - Investing.com India
Blair William & Co. IL Decreases Holdings in Agilent Technologies, Inc. $A - MarketBeat
Lab chromatographs are quietly getting an AI upgrade in the US - AD HOC NEWS
Agilent Launches Advanced Therapeutics CDMO Solution for US and Canada - Contract Pharma
Agilent’s Biocare Deal Reshapes Pathology Presence As Shares Lag Targets - simplywall.st
Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States - BioSpace
Citi Flags Agilent Technologies, Cuts Icon PLC Target, and More - AOL.com
Agilent Technologies, Inc. $A Shares Sold by Swiss National Bank - MarketBeat
Agilent launches unified CDMO division across Canada and United States - StreetInsider
Lab Chromatographs Are Quietly Getting Smarter. Here Is Why It Matters - AD HOC NEWS
Jim Cramer on Agilent Technologies: “I Don’t Think You Need It” - Yahoo Finance UK
Agilent Technologies, Inc. $A Shares Sold by Russell Investments Group Ltd. - MarketBeat
Agilent Bets On Pathology Innovation With Biocare Acquisition - Yahoo Finance
Agilent snaps up pathology firm Biocare Medical for $950 million - malaysiasun.com
Is Agilent Technologies Stock Underperforming the S&P 500? - Barchart.com
Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy - CHEManager
Van ECK Associates Corp Sells 10,815 Shares of Agilent Technologies, Inc. $A - MarketBeat
Ceredex Value Advisors LLC Makes New $24.39 Million Investment in Agilent Technologies, Inc. $A - MarketBeat
Why Agilent Technologies Just Paid $950 Million For Biocare Medical (NYSE:A) - Seeking Alpha
First Trust Advisors LP Increases Stock Position in Agilent Technologies, Inc. $A - MarketBeat
Molecular Diagnostics Market Outlook: Set to Grow at 10%+ CAGR Through 2031 as Precision Medicine and Genetic Testing Advance, Says Mordor Intelligence - GlobeNewswire Inc.
Bank of America Maintains Neutral on Agilent Technologies (A) March 2026 - Meyka
Agilent to buy Biocare Medical from Excellere and GHO Capital - pehub.com
Agilent Technologies: $950 Million Acquisition Of Pathology Diagnostics Company Biocare Medical - Pulse 2.0
Agilent Technologies to acquire Biocare Medical for $950 million - The American Bazaar
Agilent Technologies to Acquire Biocare Medical in $950 Million Deal - Clinical Lab Products
Why Agilent Stock Is Slipping Premarket Today - Stocktwits
Agilent to Acquire Biocare Medical in $950 Million All-Cash Deal - TradingView
Sullivan & Cromwell Advises Agilent On $950M Biocare Buy - Law360
Agilent to buy Biocare Medical for $950M - Healthcare Dive
Agilent Technologies to acquire Biocare Medical in $950m deal - Medical Device Network
Agilent buys Biocare for $950M - BioWorld MedTech
BofA reiterates Agilent stock rating on Biocare acquisition - Investing.com
Agilent stock rises on $950M Biocare Medical acquisition - Investing.com South Africa
Agilent expands pathology portfolio with acquisition of Biocare Medical for $950 M - BioSpectrum India
Agilent to acquire Biocare Medical in $950 million all-cash deal - PharmaLive
Sienna Gestion Sells 26,245 Shares of Agilent Technologies, Inc. $A - MarketBeat
Victory Capital Management Inc. Boosts Stake in Agilent Technologies, Inc. $A - MarketBeat
Hims & Hers shares soar premarket; Pfizer, Agilent Technologies slip - Investing.com
Agilent to acquire Biocare Medical for $950M, expanding pathology portfolio - MSN
Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions - BioSpace
M&A News: Agilent to Buy Biocare Medical for $950M — What Investors Should Know - TipRanks
Agilent Technologies, Inc. (NYSE:A) entered into a definitive agreement to acquire Biocare Medical, LLC from an investor group led by Excellere Capital Fund III LP, a fund managed by Excellere Capital Management LLC and GHO Capital Partners LLP for ap - marketscreener.com
Excellere Partners and GHO Capital Sell Biocare Medical to Agilent Technologies - National Today
Agilent Technologies to Acquire Biocare Medical for $950 Million - marketscreener.com
Agilent to buy Biocare Medical in $950 million all-cash deal - marketscreener.com
Agilent Buys Medical Instruments Maker Biocare for $950 Million - Bloomberg
0.93%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):